Home Cart 0 Sign in  
X

[ CAS No. 627-93-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 627-93-0
Chemical Structure| 627-93-0
Chemical Structure| 627-93-0
Structure of 627-93-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 627-93-0 ]

Related Doc. of [ 627-93-0 ]

Alternatived Products of [ 627-93-0 ]

Product Details of [ 627-93-0 ]

CAS No. :627-93-0 MDL No. :MFCD00008469
Formula : C8H14O4 Boiling Point : -
Linear Structure Formula :- InChI Key :UDSFAEKRVUSQDD-UHFFFAOYSA-N
M.W : 174.19 Pubchem ID :12329
Synonyms :

Calculated chemistry of [ 627-93-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.75
Num. rotatable bonds : 7
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.14
TPSA : 52.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.63 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.41
Log Po/w (XLOGP3) : 1.03
Log Po/w (WLOGP) : 0.89
Log Po/w (MLOGP) : 0.93
Log Po/w (SILICOS-IT) : 1.17
Consensus Log Po/w : 1.29

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.11
Solubility : 13.6 mg/ml ; 0.0782 mol/l
Class : Very soluble
Log S (Ali) : -1.72
Solubility : 3.28 mg/ml ; 0.0189 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.65
Solubility : 3.92 mg/ml ; 0.0225 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.5

Safety of [ 627-93-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335-H412 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 627-93-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 627-93-0 ]
  • Downstream synthetic route of [ 627-93-0 ]

[ 627-93-0 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 627-93-0 ]
  • [ 1071-93-8 ]
YieldReaction ConditionsOperation in experiment
99.2%
Stage #1: at 50 - 120℃;
Stage #2: at 125℃; for 3 h;
2.1 g (0.15 mol) of dimethyl adipate was added to a four-necked flask equipped with a stir bar, a thermometer and a separatory funnel, and then 50.4 g (0.45 mol) of acetone and nitrogen were added thereto, and the mixture was heated to 50 ° C and stirred at a constant speed. Until the two are completely miscible,The mixture was obtained; the mixture was further heated. When the temperature of the mixture reached 120 ° C, 16.2 g (0.9 mol) of water was slowly added from the separatory funnel to the mixture at a rate of 25-30 seconds per drop. 18.5g of catalyst D072 macroporous strong acid styrene cation exchange resin was added to ensure the temperature of the system was reacted at 125 ° C for about 3 h until the dimethyl adipate was completely reacted to obtain the reaction product adipic acid dihydrazide; The complete acetone and nitrogen are distilled out.The solid in the flask is subjected to crystallization treatment, and the temperature of the system is lowered to about 25 ° C, and the solid is washed with anhydrous ethanol, and washed 3-5 times.It was dried in a vacuum oven at 60 ° C for 5 h to obtain 25.9 g of a white solid.That is, the target product adipic acid dihydrazide, the yield is 99.2percent,The purity was determined by HPLC to be 99.5percent.
83% With hydrazine hydrate In isopropyl alcohol at 20℃; for 16 h; Heating The adipic acid dimethyl ester (7.5 g; 0.04 mol) was added dropwise to a solution of isopropyl alcohol (20 ml) and hydrazine hydrate (5 ml), heated to a boiling point, then the reaction mixture was allowed to stand for 16 hours at +20° C.
The precipitate was separated, washed with isopropyl alcohol, and dried.
The amount of the resulting adipic acid dihydrazide with a melting point of 182-182.5° C. was 6.2 (83percent).
81% With hydrazine hydrate In methanol at 60℃; for 5 h; General procedure: 7.6 g (100.0 mmol) of solid hydrazine (H3N + NHCO2-) and adipic acid (7.3 g, 50.0 mmol) were mixed in a mortar without a solvent for 10 minutes and stirred at 100 ° C for 5 hours. To confirm the structure and composition of the product produced in this process and analyzed using 400 MHz NMR (nuclear magnetic resonance) and elemental analysis) .As a result of the analysis, the product was adipohydrazide (C6H14N4O2), the conversion rate was 96percent or more, and the yield was 95percent or more. Yield (8.27 g, 96percent or more); The product was obtained in the same manner as in Example 1 except that 10 g of decane was used as a solvent and stirred at 110 DEG C for 12 hours and filtration and separation were carried out. The filtration and separation processes were carried out according to a known method. As a result of analysis on the product, the product was adipohydrazide (C6H14N4O2), the conversion was 97percent, and the yield was 93percent. 5.0 g (100.0 mmol) of hydrazine hydrate was used instead of the solid hydrazine8.71 g (100.0 mmol) of dimethyl adipate was used instead of adipic acid. The product was obtained by following the same procedure as in Example 3, except that 10 g of methanol was used as a solvent and the mixture was stirred at 60 ° C for 5 hours. As a result of analysis of the product, the conversion was 87percent and the yield was 81percent.
4.6 g With hydrazine In methanol at 50℃; for 1 h; To a solution of dimethyl adipate (28.7 mmol, 5.0 g, 4.7 mL, 1.0 equiv.) in 20 mL of MeOH was added anhydrous hydrazine (229.6 mmol, 7.36 g, 7.51 mL, 8.0 equiv.) and the mixture heated to 50°C, giving a white precipitate. The mixture was heated for one hour and then allowed to cool to room temperature. The white solid was collected by filtration and washed with additional MeOH then dried under high vacuum giving 4.6 g of adipohydrizide. 1HNMR (300 MHz, DMSO-d6) δ 8.91 (s, 2H), 4.14 (s, 4H), 2.00 (br s, 4H), 1.46 (br s, 4H).

Reference: [1] Patent: CN108191708, 2018, A, . Location in patent: Paragraph 0020-0033
[2] Patent: US2016/31858, 2016, A1, . Location in patent: Paragraph 0147
[3] Patent: KR2015/88523, 2015, A, . Location in patent: Paragraph 0128; 0137; 0150-0151
[4] Synthesis, 1993, # 3, p. 287 - 289
[5] J. Gen. Chem. USSR (Engl. Transl.), 1964, vol. 34, p. 341 - 344[6] Zhurnal Obshchei Khimii, 1964, vol. 34, p. 343 - 347
[7] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1997, vol. 36, # 8, p. 687 - 690
[8] Patent: WO2013/78123, 2013, A1, . Location in patent: Page/Page column 85
[9] Journal of Materials Chemistry B, 2016, vol. 4, # 5, p. 852 - 858
  • 2
  • [ 186581-53-3 ]
  • [ 110-83-8 ]
  • [ 627-93-0 ]
  • [ 2046-21-1 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1980, vol. 16, p. 453 - 463[2] Zhurnal Organicheskoi Khimii, 1980, vol. 16, # 3, p. 524 - 537
  • 3
  • [ 6654-36-0 ]
  • [ 627-93-0 ]
  • [ 1119-40-0 ]
YieldReaction ConditionsOperation in experiment
56 %Chromat. With 5H(1+)*[PMo10V2O40](5-)*H2O; oxygen In water; acetic acid at 70℃; Schlenk technique; Green chemistry General procedure: All catalytic tests were carried out using Schlenk flasks (20mL), which were attached to a vacuum line with a manometer and a gas inlet. In a typical experiment, the Schlenk was charged with 5.0mL of the corresponding solvent (CH3CN, H2O, CH3OH, CH3COOH or a mixture of CH3COOH/H2O) and HPA-n (0.02mmol). The substrate (5.0mmol) was then added and the vessel was immersed in an oil bath preheated at 70°C. O2 was introduced at atmospheric pressure and the mixture was stirred magnetically for the time indicated in the tables. Three parallel catalytic experiments were carried out for each test.
Reference: [1] Comptes Rendus Chimie, 2017, vol. 20, # 9-10, p. 888 - 895
  • 4
  • [ 186581-53-3 ]
  • [ 928-81-4 ]
  • [ 627-93-0 ]
  • [ 1119-40-0 ]
YieldReaction ConditionsOperation in experiment
60 %Chromat.
Stage #1: With 5H(1+)*[PMo10V2O40](5-)*H2O; oxygen; nickel(II) acetylacetonate In water; acetic acid at 70℃; for 8 h; Schlenk technique; Green chemistry
Stage #2: Schlenk technique; Green chemistry
General procedure: All catalytic tests were carried out using Schlenk flasks (20mL), which were attached to a vacuum line with a manometer and a gas inlet. In a typical experiment, the Schlenk was charged with 5.0mL of the corresponding solvent (CH3CN, H2O, CH3OH, CH3COOH or a mixture of CH3COOH/H2O) and HPA-n (0.02mmol). The substrate (5.0mmol) was then added and the vessel was immersed in an oil bath preheated at 70°C. O2 was introduced at atmospheric pressure and the mixture was stirred magnetically for the time indicated in the tables. Three parallel catalytic experiments were carried out for each test.
Reference: [1] Comptes Rendus Chimie, 2017, vol. 20, # 9-10, p. 888 - 895
  • 5
  • [ 186581-53-3 ]
  • [ 627-93-0 ]
  • [ 1119-40-0 ]
  • [ 106-65-0 ]
Reference: [1] Chemistry Letters, 2007, vol. 36, # 9, p. 1128 - 1129
  • 6
  • [ 186581-53-3 ]
  • [ 627-93-0 ]
  • [ 1119-40-0 ]
  • [ 106-65-0 ]
Reference: [1] Chemistry Letters, 2007, vol. 36, # 9, p. 1128 - 1129
  • 7
  • [ 67-56-1 ]
  • [ 627-93-0 ]
  • [ 4547-43-7 ]
  • [ 1119-40-0 ]
  • [ 62593-13-9 ]
Reference: [1] Patent: EP1189859, 2004, B1, . Location in patent: Page 10
  • 8
  • [ 67-56-1 ]
  • [ 110-94-1 ]
  • [ 124-04-9 ]
  • [ 627-93-0 ]
  • [ 1119-40-0 ]
Reference: [1] Patent: US2009/264674, 2009, A1, . Location in patent: Page/Page column 6-7
  • 9
  • [ 67-56-1 ]
  • [ 542-28-9 ]
  • [ 627-93-0 ]
  • [ 4547-43-7 ]
  • [ 1119-40-0 ]
  • [ 14273-92-8 ]
  • [ 931-17-9 ]
  • [ 556-48-9 ]
  • [ 106-65-0 ]
Reference: [1] Patent: EP1189859, 2004, B1, . Location in patent: Page 9
  • 10
  • [ 186581-53-3 ]
  • [ 6705-49-3 ]
  • [ 627-93-0 ]
  • [ 1119-40-0 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1984, vol. 23, # 12, p. 1190 - 1196
  • 11
  • [ 67-56-1 ]
  • [ 124-04-9 ]
  • [ 1191-25-9 ]
  • [ 556-48-9 ]
  • [ 637-88-7 ]
  • [ 542-28-9 ]
  • [ 627-93-0 ]
  • [ 4547-43-7 ]
  • [ 1119-40-0 ]
  • [ 14273-92-8 ]
  • [ 931-17-9 ]
  • [ 106-65-0 ]
Reference: [1] Patent: WO2004/46072, 2004, A1, . Location in patent: Page/Page column 9-10
  • 12
  • [ 67-56-1 ]
  • [ 64-18-6 ]
  • [ 110-94-1 ]
  • [ 124-04-9 ]
  • [ 1191-25-9 ]
  • [ 13392-69-3 ]
  • [ 556-48-9 ]
  • [ 627-93-0 ]
  • [ 4547-43-7 ]
  • [ 1119-40-0 ]
  • [ 14273-92-8 ]
  • [ 931-17-9 ]
  • [ 106-65-0 ]
Reference: [1] Patent: WO2006/48170, 2006, A1, . Location in patent: Page/Page column 13
  • 13
  • [ 186581-53-3 ]
  • [ 112-63-0 ]
  • [ 553-90-2 ]
  • [ 627-93-0 ]
  • [ 1732-10-1 ]
  • [ 1119-40-0 ]
  • [ 1732-09-8 ]
  • [ 106-65-0 ]
Reference: [1] Monatshefte fuer Chemie, 1991, vol. 122, # 8, p. 719 - 724
  • 14
  • [ 67-56-1 ]
  • [ 64-18-6 ]
  • [ 110-94-1 ]
  • [ 124-04-9 ]
  • [ 1191-25-9 ]
  • [ 13392-69-3 ]
  • [ 556-48-9 ]
  • [ 542-28-9 ]
  • [ 627-93-0 ]
  • [ 4547-43-7 ]
  • [ 1119-40-0 ]
  • [ 14273-92-8 ]
  • [ 931-17-9 ]
  • [ 106-65-0 ]
Reference: [1] Patent: WO2004/26798, 2004, A2, . Location in patent: Page/Page column 10
  • 15
  • [ 627-93-0 ]
  • [ 1194-18-9 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 4, p. 1098 - 1101
[2] Synthesis, 1995, # 11, p. 1432 - 1444
  • 16
  • [ 627-93-0 ]
  • [ 3294-60-8 ]
  • [ 1194-18-9 ]
Reference: [1] Chemische Berichte, 1977, vol. 110, p. 3118 - 3125
Same Skeleton Products
Historical Records